[go: up one dir, main page]

WO2002014364A3 - Rattlesnake venom gland proteins - Google Patents

Rattlesnake venom gland proteins Download PDF

Info

Publication number
WO2002014364A3
WO2002014364A3 PCT/US2001/025310 US0125310W WO0214364A3 WO 2002014364 A3 WO2002014364 A3 WO 2002014364A3 US 0125310 W US0125310 W US 0125310W WO 0214364 A3 WO0214364 A3 WO 0214364A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
venom
venom gland
snake
gland proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/025310
Other languages
French (fr)
Other versions
WO2002014364A2 (en
Inventor
Paul O Sheppard
Paul D Bishop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU2001283334A priority Critical patent/AU2001283334A1/en
Publication of WO2002014364A2 publication Critical patent/WO2002014364A2/en
Publication of WO2002014364A3 publication Critical patent/WO2002014364A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Due to their biological activity, snake venom proteins have found a variety of uses in therapeutic and diagnostic applications. Zsnk proteins are C-type lectin proteins expressed in the venom gland of the pigmy rattlesnake Sistrurus miliarius. This species is a member of the Viperidae, a snake family known for producing venom that affects the blood coagulation and platelet aggregation system.
PCT/US2001/025310 2000-08-14 2001-08-13 Rattlesnake venom gland proteins Ceased WO2002014364A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001283334A AU2001283334A1 (en) 2000-08-14 2001-08-13 Rattlesnake venom gland proteins

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US22507200P 2000-08-14 2000-08-14
US22508700P 2000-08-14 2000-08-14
US60/225,087 2000-08-14
US60/225,072 2000-08-14
US22549000P 2000-08-15 2000-08-15
US22548900P 2000-08-15 2000-08-15
US60/225,489 2000-08-15
US60/225,490 2000-08-15
US35699700P 2000-12-20 2000-12-20
US60/356,997 2000-12-20

Publications (2)

Publication Number Publication Date
WO2002014364A2 WO2002014364A2 (en) 2002-02-21
WO2002014364A3 true WO2002014364A3 (en) 2003-01-23

Family

ID=27539886

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/025310 Ceased WO2002014364A2 (en) 2000-08-14 2001-08-13 Rattlesnake venom gland proteins

Country Status (2)

Country Link
AU (1) AU2001283334A1 (en)
WO (1) WO2002014364A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344783A (en) * 1989-06-16 1994-09-06 Cor Therapeutics, Inc. Platelet aggregation inhibitors
EP0775711A1 (en) * 1993-09-22 1997-05-28 Ajinomoto Co., Inc. Peptide having antithrombotic activity and process for producing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344783A (en) * 1989-06-16 1994-09-06 Cor Therapeutics, Inc. Platelet aggregation inhibitors
EP0775711A1 (en) * 1993-09-22 1997-05-28 Ajinomoto Co., Inc. Peptide having antithrombotic activity and process for producing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MATSUZAKI RYOICHI ET AL: "CDNA cloning of IX/X-BP, a heterogenesis two-chain anticoagulant protein from snake venom.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 220, no. 2, 1996, pages 382 - 387, XP002210987, ISSN: 0006-291X *

Also Published As

Publication number Publication date
WO2002014364A2 (en) 2002-02-21
AU2001283334A1 (en) 2002-02-25

Similar Documents

Publication Publication Date Title
AU2002344492A1 (en) Three-way stopcock, and liquid transfusion tubing set or blood transfusion tubing set using the three-way stopcock
WO2002061090A3 (en) Prokaryotically produced antibodies and uses thereof
EP1777234A3 (en) Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2
ATE332668T1 (en) MEDICAL DEVICE FOR BLOOD FLOW CONTROL
ATE311226T1 (en) THE GLYCINE BETAIN FOR ITS ANTITHROMBOTIC USE
ES2168361T3 (en) DNA SEQUENCES FOR METALOPROTEASES OF THE MATRIX, ITS PREPARATION AND EMPLOYMENT.
DE50001376D1 (en) IMMUNADSORBER FOR SEPSIS THERAPY
WO2004060381A8 (en) Rabbit skin comprising biological active substance and its use
WO2004065406A3 (en) Rantes-derived peptides with anti-hiv activity
WO2002014364A3 (en) Rattlesnake venom gland proteins
WO1999058098A8 (en) HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO
AU2001232736A1 (en) Protein c derivatives
AU3338699A (en) Medical devices treated to discourage blood coagulation
WO2019236658A3 (en) Pic1 peptide compositions and methods of use thereof for treatment of drug-induced immune hemolytic anemia
WO2001038501A3 (en) Human serine protease
CA2333252A1 (en) Use of bromelain proteases for inhibiting blood coagulation
BR0211533A (en) Treatment of chronic pain with 3-heterocyclyl and 3-cycloalkyl-3-aryloxypropanamines
RU2002120163A (en) METHOD FOR PRODUCING THROMBIN-LIKE COAGULATING ENZYME
Schetz et al. CRRT and ECMO: Dialysis catheter or connection to the ECMO circuit?
Arocha-Pinango et al. Effect of some animal venoms and secretions on the hemostatic mechanism.
WO2001066771A3 (en) Human serine protease
AU2001282455A1 (en) Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen
RU2001101202A (en) METHOD FOR SURGICAL TREATMENT OF PATIENTS WITH ARTERIAL OCCLUSIONS
Lifshitz et al. Snake bite by Cerastes vipera in children: report of two cases
RU2008018C1 (en) Method of prostate gland secretion preparing at chronic prostatitis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP